Gland Pharma Limited
GLAND
Classificação em ações
#3291
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Preço da ação
$31.12
Valor de mercado
$5.14B
Variação (1 dia)
-3.71%
Variação (1 ano)
42.50%
País
IN
Negociar Gland Pharma Limited (GLAND)
Categoria
Healthcare
Receita da Gland Pharma Limited (GLAND)
Receita em Jun 2026 TTM: $742.20M
De acordo com os últimos relatórios financeiros da Gland Pharma Limited, a receita atual da empresa (TTM) é $742.20M. Em 2024, a empresa obteve uma receita de $679.36M um aumento em relação a a receita do ano 2023, que foi de $441.05M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Gland Pharma Limited de 2017 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $742.20M | 13.02% |
| 2025 | $656.70M | -3.34% |
| 2024 | $679.36M | 54.03% |
| 2023 | $441.05M | -23.92% |
| 2022 | $579.73M | 22.55% |
| 2021 | $473.05M | 35.33% |
| 2020 | $349.54M | 18.74% |
| 2019 | $294.38M | 18.32% |
| 2018 | $248.80M | 9.08% |
| 2017 | $228.10M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
